The reality of weight regain after medication

If you’ve followed health news over the past few years, you’ve probably heard about the so-called “miracle” weight-loss drugs. Medications like semaglutide (sold under names such as Wegovy and Ozempic), tirzepatide (Zepbound), and other anti-obesity medications (AOMs) have been hailed as game changers in the fight against obesity. Stories abound of people shedding dozens of pounds, lowering their blood pressure, and even reversing diabetes risk factors.

But there’s a quieter, less glamorous question that often lingers in the background: what happens when you stop taking these drugs?

A study published in BMC Medicine tackles that very question. The research, conducted by Dr. Han Wu and colleagues at the Department of Endocrinology and Metabolism at Peking University People’s Hospital in Beijing, systematically analyzed what happens to people’s weight after discontinuing anti-obesity medications. Their findings paint a sobering, though perhaps unsurprising, picture: weight tends to creep back. And it happens sooner than many might think.

Obesity is one of the defining health challenges of our time. More than 2.2 billion adults worldwide were overweight or obese in 2020, and projections suggest that number could soar to 3.3 billion by 2035. Obesity isn’t just about body image, it’s tied to a higher risk of heart disease, diabetes, stroke, and even some cancers.

While lifestyle changes such as diet and exercise are always the first line of defense, doctors now have six FDA-approved anti-obesity drugs at their disposal: orlistat, naltrexone-bupropion, liraglutide, semaglutide, tirzepatide, and phentermine-topiramate. These medications have been shown to produce impressive weight loss when used long term.

The thing is that few people stay on these drugs forever. Some stop because of side effects, others because of cost (many insurance plans don’t cover them), and some because they feel they’ve reached their goals. But the real question is whether the hard-earned weight loss lasts after the prescription runs out.

Therefore, Wu and colleagues combed through databases of randomized controlled trials, which is the gold standard of medical research, to identify studies where participants took anti-obesity drugs for at least four weeks, then were followed for at least four more weeks after stopping.

In total, they included 11 studies with over 2,400 participants. The medications studied ranged from older drugs like orlistat to newer ones like semaglutide and tirzepatide. Then they did what’s called a meta-analysis, consisting in pooling the data from all these studies to get a clearer, more reliable picture of what happens post-treatment.

And here’s what they found. Four weeks after stopping medication, the benefits were still holding: participants weighed slightly less than their peers in control groups. However, by eight weeks, the tide began to turn. People who had been on weight-loss drugs were now regaining weight faster than those who had never taken them. At 12 and 20 weeks, the trend was undeniable: significant weight regain was underway. On average, participants gained back 1.5 to 2.5 kilograms (3–5 pounds) compared to controls. By a year out, most of the weight loss had eroded, though many participants were still lighter than they had been before starting treatment.

In other words: the benefits of anti-obesity drugs fade quickly once the prescription stops.

Why does the weight come back?

The body is stubborn when it comes to weight. From an evolutionary perspective, that makes sense: our ancestors didn’t want to waste away when food was scarce. When someone loses weight, especially quickly, the body activates a series of defenses to restore the lost pounds.

Scientists call this metabolic adaptation. Resting metabolism slows, appetite hormones shift, and cravings intensify. The gut and brain work together to nudge you toward eating more. It’s not just about willpower; these are powerful biological forces.

For drugs like semaglutide and tirzepatide, which mimic hormones that regulate appetite and digestion, the story is even clearer. They work beautifully while you’re on them, making you feel fuller with less food. But once you stop, those helpful hormone signals vanish. Your old appetite returns, and with it, so does the weight.

Wu’s study found this pattern most strongly with the GLP-1 class of drugs (which includes semaglutide and liraglutide). People on these medications tended to lose more weight up front, but also regained more when they stopped.

Not everything in the study lined up with common assumptions. For example, you might think people with a higher body mass index (BMI) would be more prone to weight regain. But the researchers found the opposite: participants with lower BMIs actually regained more.

Another surprise came from lifestyle interventions. People who continued diet and exercise programs after stopping the drugs still regained weight. This doesn’t mean lifestyle changes don’t work, it just shows how powerful the body’s weight-regain mechanisms can be.

So, should you stay on the meds forever?

That’s the million-dollar question. The findings of this study echo a broader truth: obesity is a chronic condition, not a temporary one. Just as people with high blood pressure often need lifelong medication, people with obesity may need ongoing treatment.

But that doesn’t mean everyone should be on weight-loss drugs indefinitely. Cost, side effects, and personal goals all matter. Some people might use these medications as a “kick-start,” then transition to lifestyle strategies. Others may need them long term, much like someone with diabetes stays on insulin.

Wu and colleagues stop short of prescribing a one-size-fits-all solution. Instead, they emphasize the need for more long-term studies to understand how best to manage weight after stopping medication, and how to minimize the rebound effect. Wu and colleagues’ study makes one thing clear: the fight against obesity doesn’t end when the pills run out.

Weight-loss medications can deliver powerful results, but once discontinued, the body often pushes back, sometimes within just a couple of months. That doesn’t mean these drugs aren’t worth using; it means they should be seen as part of a broader, ongoing strategy to manage weight and health. For those struggling with weight, it's a long-term journey. Patience, persistence, and compassion are essential. But the reward is better health.

If you want to learn more, the original article titled "Trajectory of the body weight after drug discontinuation in the treatment of anti-obesity medications" on BMC Medicine at https://doi.org/10.1186/s12916-025-04200-0.